Wpharma SRL
The score of Wpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +24 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Wpharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 24 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 19 Jul 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Wpharma's financial analysis
- Solvency71.6%sector median: 53.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Wpharma
Wpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0898.266.619
- VAT number
- BE0898266619
- Peppol
- Registered · 0208:0898266619 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 May 2008
- Registered office
- 2880 Bornem
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Activities of head offices (NACE 70100)
Wpharma (SRL) has been based in Bornem since 2008, active in: activities of head offices. For 2025, it reports a net profit of 47,204 € and equity of 688,259 €; its revenue is not published. Its solvency stands at 71.6%, above the median of its sector (53.1%).
Companies similar to Wpharma
Companies in the same business, of comparable size and area, outside its group.
- TDC Activities of head offices Sankt Vith · balance sheet 963,162 €
- QE Invest Activities of head offices Schoten · balance sheet 951,498 €
- Axelleon Activities of head offices Erpe-Mere · balance sheet €1.02m
- Societe DE Developpement ET DE Management Activities of head offices Thuin · balance sheet 938,999 €
- Bewali Activities of head offices Avelgem · balance sheet 935,993 €
- Domus Fructus Activities of head offices Waasmunster · balance sheet 928,812 €
- M.T. Consulting Activities of head offices Couvin · balance sheet 999,005 €
- Polyfosa Activities of head offices Sankt Vith · balance sheet €1.01m
Frequently asked questions about Wpharma
What is the revenue of Wpharma?
Wpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Wpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0898266619 for Wpharma, if the company is VAT-registered. Its company number (CBE) is 0898.266.619.
Where is the registered office of Wpharma?
According to the CBE register, the registered office of Wpharma is in 2880 Bornem.
What is the equity of Wpharma?
At the close of the 2025 financial year, the equity of Wpharma amounts to 688,259 €, a solvency of 71.6% of total assets.
Who manages Wpharma?
The register lists 1 active mandates at Wpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Wpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →